Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects

NCT02820155 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: RGN1016
DRUG: Placebo

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]